Literature DB >> 24415515

Quality of life and voice assessment in patients with early-stage glottic cancer.

Fernando Arias1, Juan Ignacio Arraras, Gemma Asin, María Itziar Uzcanga, Enrique Maraví, Volker Chicata, Clara Eito, Uxue Zarandona, Itxaso Mora, Meritxell Vila, Miguel Angel Domínguez.   

Abstract

BACKGROUND: The purpose of this study was to assess the quality of life (QOL) and voice handicap in a sample of disease-free patients who had been treated at our center with radiotherapy (RT) or surgery for early glottic cancer.
METHODS: QOL and voice handicap were assessed using the European Organisation for Research and Treatment of Cancer (EORTC) questionnaires Quality of Life Questionnaire-Core 30-questions (QLQ-C30) and Quality of Life Questionnaire-Head and Neck 35-questions (QLQ-H&N35) and the Voice Handicap Index (VHI).
RESULTS: Ninety-one patients completed the questionnaires. Fifty-nine patients (65%) were treated with RT and 32 (35%) with surgery. QOL scores for the sample recorded, moderate limitations in 6 areas, and more than moderate limitations (>30 of 100) in 2 areas. Significant differences were found in emotional functioning (88.5 vs 76.6) and social contact (4.6 vs 12.1) on the EORTC questionnaires and on the VHI (6.1 vs 12.8), which favored the RT group.
CONCLUSION: In this cross-sectional study, voice quality, emotional functioning, and social contact were better in the RT group.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  glottic cancer; quality of life; quality of voice; radiotherapy

Mesh:

Year:  2014        PMID: 24415515     DOI: 10.1002/hed.23603

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.

Authors:  B G Salas-Salas; D J Domínguez-Nuez; R Cabrera; L Ferrera-Alayón; M Lloret; P C Lara
Journal:  Clin Transl Oncol       Date:  2019-06-01       Impact factor: 3.405

2.  Radiotherapy Versus Surgery-Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms.

Authors:  Yajing Du; Shali Shao; Minghe Lv; Yi Zhu; Li Yan; Tiankui Qiao
Journal:  Front Oncol       Date:  2020-08-26       Impact factor: 6.244

3.  Asymptomatic swallowing disorders may be present in individuals with laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy.

Authors:  César Álvarez-Marcos; Andrea Vicente Benito; Agueda Gayol Fernández; Daniel Pedregal-Mallo; Paloma Sirgo Rodríguez; Liliana Santamarina Rabanal; José Luis Llorente; Fernando López; Juan Pablo Rodrigo
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-07       Impact factor: 2.503

4.  Evolution of voice after transoral laser cordectomy for precancerous lesions and early glottic cancer.

Authors:  Lucia Staníková; Karol Zeleník; Martin Formánek; Jana Seko; Radana Walderová; Peter Kántor; Pavel Komínek
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-18       Impact factor: 2.503

5.  Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.

Authors:  Seung Yeun Chung; Kyung Hwan Kim; Ki Chang Keum; Yoon Woo Koh; Se-Heon Kim; Eun Chang Choi; Chang Geol Lee
Journal:  Cancer Res Treat       Date:  2017-03-17       Impact factor: 4.679

6.  Voice outcomes in patients with advanced laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy.

Authors:  César Álvarez-Marcos; Andrea Vicente-Benito; Águeda Gayol-Fernández; Daniel Pedregal-Mallo; Paloma Sirgo-Rodríguez; Liliana Santamarina-Rabanal; José Luis Llorente; Fernando López; Juan Pablo Rodrigo
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-06       Impact factor: 2.618

7.  Analysis of prognostic factors for Tis-2N0M0 early glottic cancer with different treatment methods.

Authors:  Guanyu Wang; Guodong Li; Jianjun Wu; Penghui Song
Journal:  Braz J Otorhinolaryngol       Date:  2020-08-06

8.  Surgery versus radiotherapy: Long term outcomes of T1 glottic cancer.

Authors:  Nelson Ferreira; Eduardo Netto; Leonor Fonseca; João Fonseca; Susana Esteves; Miguel Labareda; António Mota; Rute Pocinho; Miguel Magalhães; Filomena Santos
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.